Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients

NCT06265259 is registered in ClinicalTrials.gov with University of Thessaly as lead sponsor.

NCT NCT06265259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06265259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients
Lead sponsor
University of Thessaly
Phase
Phase 4
Overall status
Unknown status
Start date
December 15, 2023
Completion date
January 31, 2026
Enrollment
145 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulatory shock